GoodRx Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated November 4, 2025, announces the financial results for GoodRx Holdings, Inc. for the three and nine months ended September 30, 2025. The Company is incorporated in Delaware and its Class A Common Stock trades on The Nasdaq Stock Market LLC under the symbol GDRX.
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release (Exhibit 99.1) for detailed data. Consequently, specific numerical values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this text. The filing does not provide a clear value for any specific financial metric.
Material Changes
The filing text does not contain specific data regarding material changes versus prior comparable periods. Investors must refer to the attached press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. These disclosures are contained within the referenced press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and cash flow figures for the three and nine months ended September 30, 2025.
- Verify year-over-year growth rates and margin trends in the full press release.
- Check for any updated financial guidance or strategic outlook provided in the press release.
- Confirm the status of debt obligations and liquidity positions as detailed in the full financial results.